125 related articles for article (PubMed ID: 33538240)
1. SARS-CoV-2 and self-medication in Cameroon: a mathematical model.
Kong JD; Tchuendom RF; Adeleye SA; David JF; Admasu FS; Bakare EA; Siewe N
J Biol Dyn; 2021 Dec; 15(1):137-150. PubMed ID: 33538240
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon.
Nkwayep CH; Bowong S; Tsanou B; Alaoui MAA; Kurths J
Math Med Biol; 2022 Feb; 39(1):1-48. PubMed ID: 35045180
[TBL] [Abstract][Full Text] [Related]
3. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
5. Simulating the progression of the COVID-19 disease in Cameroon using SIR models.
Nguemdjo U; Meno F; Dongfack A; Ventelou B
PLoS One; 2020; 15(8):e0237832. PubMed ID: 32841283
[TBL] [Abstract][Full Text] [Related]
6. Impact assessment of self-medication on COVID-19 prevalence in Gauteng, South Africa, using an age-structured disease transmission modelling framework.
Avusuglo WS; Han Q; Woldegerima WA; Bragazzi N; Asgary A; Ahmadi A; Orbinski J; Wu J; Mellado B; Kong JD
BMC Public Health; 2024 Jun; 24(1):1540. PubMed ID: 38849785
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2: exposure to high external doses as determinants of higher viral loads and of increased risk for COVID-19. A systematic review of the literature.
Calisti R
Epidemiol Prev; 2020; 44(5-6 Suppl 2):152-159. PubMed ID: 33412806
[TBL] [Abstract][Full Text] [Related]
8. The Pathogenesis and Treatment of COVID-19: A System Review.
Ji YL; Wu Y; Qiu Z; Ming H; Zhang Y; Zhang AN; Leng Y; Xia ZY
Biomed Environ Sci; 2021 Jan; 34(1):50-60. PubMed ID: 33531107
[No Abstract] [Full Text] [Related]
9. Predictive model with analysis of the initial spread of COVID-19 in India.
Ghosh S
Int J Med Inform; 2020 Nov; 143():104262. PubMed ID: 32911257
[TBL] [Abstract][Full Text] [Related]
10. Deterministic and stochastic models for the epidemic dynamics of COVID-19 in Wuhan, China.
Olabode D; Culp J; Fisher A; Tower A; Hull-Nye D; Wang X
Math Biosci Eng; 2021 Jan; 18(1):950-967. PubMed ID: 33525127
[TBL] [Abstract][Full Text] [Related]
11. [Analysis and future scenarios of the SARS-CoV-2 epidemic in Tuscany Region (Central Italy)].
Cereda G; Viscardi C; Gottard A; Mealli F; Baccini M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):120-127. PubMed ID: 33412802
[TBL] [Abstract][Full Text] [Related]
12. The role of respiratory therapists in fighting the COVID-19 crisis: unsung heroes in Wuhan.
Tu GW; Liu K; Su Y; Yu SJ; Ju MJ; Luo Z
Ann Palliat Med; 2020 Nov; 9(6):4423-4426. PubMed ID: 33222451
[No Abstract] [Full Text] [Related]
13. Randomized Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.
Lyman GH; Kuderer NM
Cancer Invest; 2020 Nov; 38(10):537-542. PubMed ID: 33090883
[No Abstract] [Full Text] [Related]
14. Assessing self-medication for obstructive airway disease during COVID-19 using
Sahanic S; Boehm A; Pizzini A; Sonnweber T; Aichner M; Weiss G; Loeffler-Ragg J; Tancevski I
Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32943405
[TBL] [Abstract][Full Text] [Related]
15. Application of artificial neural networks to predict the COVID-19 outbreak.
Niazkar HR; Niazkar M
Glob Health Res Policy; 2020 Nov; 5(1):50. PubMed ID: 33292780
[TBL] [Abstract][Full Text] [Related]
16. Trends in adaptation of fifteen European countries population to SARS-CoV-2 in March-May 2020: Can Taiwanese experience be adopted?
Sharov KS
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):679-687. PubMed ID: 32798031
[TBL] [Abstract][Full Text] [Related]
17. The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model.
Cabore JW; Karamagi HC; Kipruto H; Asamani JA; Droti B; Seydi ABW; Titi-Ofei R; Impouma B; Yao M; Yoti Z; Zawaira F; Tumusiime P; Talisuna A; Kasolo FC; Moeti MR
BMJ Glob Health; 2020 May; 5(5):. PubMed ID: 32451366
[TBL] [Abstract][Full Text] [Related]
18. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis?
Katsidzira L; Gwaunza L; Hakim JG
Clin Infect Dis; 2020 Nov; 71(16):2180-2183. PubMed ID: 32392333
[TBL] [Abstract][Full Text] [Related]
19. A rational approach to COVID-19.
Mehrian-Shai R
Hum Genomics; 2020 Dec; 14(1):47. PubMed ID: 33353565
[TBL] [Abstract][Full Text] [Related]
20. Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2.
Jackson ML
Microbes Infect; 2020; 22(10):611-616. PubMed ID: 32977019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
